NewsEric Bennett

U.S. Para Archers Now Two-Thirds Of The Way To Paralympic Games

by Todd Kortemeier

Martha Chavez poses after making the podium at the Parapan American Games Toronto 2015. 

 

Four U.S. Para archers started the Paralympic qualification process off right with wins in Stage 1 and Stage 2 of the U.S. Paralympic Team Trials for Archery over the weekend in Newberry, Florida.
Eric Bennett (recurve), Martha Chavez (compound), Lisa Coryell (W1 compound) and Emma Rose Ravish (recurve) all went 2-for-2 in the 72-arrow rounds that make up the first two stages of Trials. That means each will start the all-important Stage 3 of the trials, held June 3 in Chula Vista, California, in prime position to secure a Paralympic berth.
Bennett is going after a fourth Paralympic Games, and is still seeking his first career medal. His best performance to date was in London in 2012, finishing fourth. Bennett won a world championship in 2015.
Chavez is seeking her first Paralympic Games. She is a former Parapan American Games medalist. The U.S. still needs to qualify a quota spot in Chavez’s compound open division, which it can do at a world qualification tournament in July.
Coryell is Team USA’s only woman in W1. The 2016 Paralympian is taking one more shot at a Paralympic medal after battling through numerous health issues in the past. Coryell secured her W1 quota spot with a gold medal in March at the Para Pan American Championships. 
Ravish also secured her spot in March, by taking silver in women’s recurve. That was her first career international medal. The rising star had her first international competition in 2019 when she qualified for the world championships. 
Not competing in Newberry were the men’s compound open athletes. Positive COVID-19 tests forced that competition to be postponed. Information on how those Trials will proceed is forthcoming from USA Archery.


Todd Kortemeier is a sportswriter, editor and children’s book author from Minneapolis. He is a contributor to TeamUSA.org on behalf of Red Line Editorial, Inc.